US obesity organisations call for better testing and labelling of drugs for people with obesity
The Obesity Action Coalition (OAC) announces the publication of a ‘Joint statement in support of closing gaps in the drug approval...
top of page
Browse by category
Search
FDA warns against using compounded semaglutide
The FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...
nanoMesh files second PMA (510(k)) with FDA for Exogenesis Hernia Mesh
nanoMesh, a subsidiary of Exogenesis, has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with...
Browse by tag
bottom of page